Literature DB >> 11943264

Leishmania in discarded syringes from intravenous drug users.

I Cruz1, M A Morales, I Noguer, A Rodríguez, J Alvar.   

Abstract

Needle sharing by intravenous drug users (IVDUs) has been proposed as providing an alternative, artificial, and anthroponotic cycle for leishmania transmission. We looked for parasites in syringes discarded by IVDUs using two different PCR techniques. Leishmania spp were detected in 65 (52%) of 125 syringes collected in southern Madrid, Spain, in 1998, and in 52 (34%) of 154 collected in southwestern Madrid in 2000-01. We found shared restriction fragment length polymorphisms in 12 of 65 positive samples tested, suggesting that syringe sharing can indeed promote the spread of leishmania clones among IVDUs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943264     DOI: 10.1016/s0140-6736(02)08160-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  33 in total

1.  Visceral leishmaniasis presenting as subcutaneous nodules in a HIV-positive patient.

Authors:  K Göbels; T Feldt; M Oette; J Richter; G Harms; M P Grobusch; M Sarbia; D Häussinger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-08       Impact factor: 3.267

2.  Enzyme-linked immunosorbent assays for diagnosis of leishmaniasis in patients coinfected with human immunodeficiency virus.

Authors:  Subhash C Arya
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 3.  Diagnosis of visceral leishmaniasis.

Authors:  Pankaj Srivastava; Anand Dayama; Sanjana Mehrotra; Shyam Sundar
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-11-11       Impact factor: 2.184

Review 4.  Molecular diagnosis of leishmaniasis: current status and future applications.

Authors:  Richard Reithinger; Jean-Claude Dujardin
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

Review 5.  Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis.

Authors:  Melanie Walker; James G Kublin; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-11-23       Impact factor: 9.079

Review 6.  Drug resistance in leishmaniasis.

Authors:  Simon L Croft; Shyam Sundar; Alan H Fairlamb
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

7.  Comparison of point-of-care tests for the rapid diagnosis of visceral leishmaniasis in East African patients.

Authors:  Asrat Bezuneh; Maowia Mukhtar; Asim Abdoun; Tedla Teferi; Yegnasew Takele; Ermias Diro; Asfaw Jemaneh; Welelta Shiferaw; Hirut Wondimu; Ajay Bhatia; Randall F Howard; Hashim Ghalib; Gregory C Ireton; Asrat Hailu; Steven G Reed
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

8.  Strategies for reducing the risk of transfusion-transmitted leishmaniasis in an area endemic for Leishmania infantum: a patient- and donor-targeted approach.

Authors:  Teresa Jimenez-Marco; Cristina Riera; Enrique Girona-Llobera; Carmen Guillen; Laura Iniesta; Magdalena Alcover; Diana Berenguer; Alba Pujol; Miriam Tomás-Pérez; Beatriz Cancino-Faure; Teresa Serra; Martín Mascaró; Joan Gascó; Roser Fisa
Journal:  Blood Transfus       Date:  2017-03-15       Impact factor: 3.443

Review 9.  Leishmaniasis.

Authors:  T V Piscopo; A C Mallia
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

10.  Human immunodeficiency virus and leishmaniasis.

Authors:  Navid Ezra; Maria Teresa Ochoa; Noah Craft
Journal:  J Glob Infect Dis       Date:  2010-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.